(1.02%) 5 099.96 points
(0.40%) 38 240 points
(2.03%) 15 928 points
(0.11%) $83.66
(-3.32%) $1.920
(0.30%) $2 349.60
(-0.43%) $27.52
(0.42%) $924.40
(0.32%) $0.935
(0.67%) $11.02
(0.13%) $0.800
(-0.07%) $92.11
0.01% $ 68.49
Live Chart Being Loaded With Signals
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD)...
Stats | |
---|---|
Dzisiejszy wolumen | 3.28M |
Średni wolumen | 0 |
Kapitalizacja rynkowa | 0.00 |
EPS | $0 ( 2022-11-02 ) |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -14.08 |
ATR14 | $0.890 (1.30%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2022-10-05 | Perry Mark L | Sell | 5 600 | Stock Option (Right to Buy) |
2022-10-05 | Patrick Deval L | Sell | 5 600 | Stock Option (Right to Buy) |
2022-10-05 | Morrison Scott W | Sell | 5 600 | Stock Option (Right to Buy) |
2022-10-05 | Thompson Alexis A. | Sell | 3 600 | Restricted Stock Units |
2022-10-05 | Yarno Wendy L | Sell | 30 000 | Stock Option (Right to Buy) |
INSIDER POWER |
---|
-60.35 |
Last 100 transactions |
Buy: 278 284 | Sell: 1 075 911 |
Wolumen Korelacja
Global Blood Korelacja
10 Najbardziej pozytywne korelacje |
---|
10 Najbardziej negatywne korelacje |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Global Blood Korelacja - Waluta/Towar
Global Blood Finanse
Annual | 2021 |
Przychody: | $194.75M |
Zysk brutto: | $191.43M (98.30 %) |
EPS: | $-4.82 |
FY | 2021 |
Przychody: | $194.75M |
Zysk brutto: | $191.43M (98.30 %) |
EPS: | $-4.82 |
FY | 2020 |
Przychody: | $123.80M |
Zysk brutto: | $121.82M (98.40 %) |
EPS: | $-4.04 |
FY | 2019 |
Przychody: | $2.11M |
Zysk brutto: | $2.06M (97.72 %) |
EPS: | $-4.57 |
Financial Reports:
No articles found.
Global Blood
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses of Oxbryta in a Phase II a clinical trial of adolescent and pediatric patients with SCD. In addition, the company is developing its lead product candidate inclacumab, novel human monoclonal antibody, which is in Phase III a clinical trial to reduce the incidence of painful vaso-occlusive crises, and resulting hospital admissions; and GBT601, a hemoglobin polymerization inhibitor that is in Phase I development. It has a license and collaboration agreement with Syros Pharmaceuticals, Inc. to discover, develop, and commercialize therapies for SCD and beta thalassemia; and Sanofi S.A. to two early-stage research programs in SCD. Global Blood Therapeutics, Inc. was incorporated in 2011 and is headquartered in South San Francisco, California.
O Sygnały na żywo
Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.
Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej